Get 20% lifetime commission for referring investors to digrin.com
here.
REGENXBIO Inc. ( RGNX) - Key Metrics
RGNX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.05 | $0.43 | -$1.18 | -$1.19 |
| 2026Q1 | $0.12 | -$1.72 | -$1.45 | -$1.48 |
| 2025Q4 | $0.59 | -$1.30 | -$1.01 | -$1.02 |
| 2025Q3 | $0.58 | -$1.20 | -$1.08 | -$1.09 |
| 2025Q2 | $0.41 | -$1.38 | -$0.96 | -$0.97 |
RGNX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 6.97 |
| 2026Q1 | 0% | -1.22 |
| 2025Q4 | 0% | -2.77 |
| 2025Q3 | 0% | -2.01 |
| 2025Q2 | 0% | -1.49 |
RGNX
Price: $6.92
52 week price:
Earnings Per Share: -3.78 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 295200
Ebitda: -20.6 millionMarket Capitalization: 401.2 million